329
Participants
Start Date
July 8, 2021
Primary Completion Date
April 30, 2023
Study Completion Date
July 31, 2023
Bodyport Cardiac Scale
The Bodyport Cardiac Scale is capable of measuring key HF parameters of congestion and cardiac perfusion on a regular basis in a patient's home. These data will be combined into a composite index that may be used to identify patients at increased risk for decompensation, inform the reason for their decline, and offer the possibility to remotely optimize therapy to prevent further worsening HF.
Temple University - Lewis Katz School of Medicine, Philadelphia
Duke University Medical Center, Durham
Self Regional Healthcare Research Center, Hodges
The Heart Center of Northeast Georgia Medical Center, Gainesville
Cardiovascular Institute of Northwest Florida, Panama City
RecioMed Clinical Research Network, Inc., Boynton Beach
Wayne State University, Detroit
University of Kansas School of Medicine, Kansas City
Collaborators (1)
Duke Clinical Research Institute
OTHER
Bodyport Inc.
INDUSTRY